Live from the NIH registry
Studies recruiting near Little Rock right now
Top 25 of 513 recruiting studies, sorted by proximity — each links to its official registry page
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,209 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: NRG Oncology
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Phase 2
Interventional 98 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Giselle Sholler
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Clinical Trials, Inc — Little Rock, Arkansas (4.1 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Cognitive Impairment Associated With Schizophrenia (CIAS)
Phase 2
Interventional 150 participants sought
Woodland International Research Group — Little Rock, Arkansas (4.1 mi)
· Sponsor: Kynexis B.V.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Medical Investigations — Little Rock, Arkansas (4.1 mi)
· Sponsor: Medtronic MiniMed, Inc.
The Pediatric Anesthesia Quality Improvement Project
Surgery, Anesthesia
N/A
Observational 5,000,000 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: The Society for Pediatric Anesthesia
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: SWOG Cancer Research Network
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Schizophrenia, Bipolar I Disorder
Phase 3
Interventional 220 participants sought
Alkermes Investigator Site — Little Rock, Arkansas (4.1 mi)
· Sponsor: Alkermes, Inc.
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Childhood Medulloblastoma
Phase 3
Interventional 225 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Children's Oncology Group
Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Neuroblastoma
Phase 2
Interventional 500 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Giselle Sholler
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
Langerhan's Cell Histiocytosis, Juvenile Xanthogranuloma
Phase 2
Interventional 90 participants sought
Arkansas Children's Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Carl Allen
SELUTION4BTK Trial
Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
N/A
Interventional 376 participants sought
Arkansas Heart Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: M.A. Med Alliance S.A.
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age
Lymphatic Malformation
Phase 2
Interventional 38 participants sought
Arkansas Children's Hospital/UAMS — Little Rock, Arkansas (4.1 mi)
· Sponsor: Protara Therapeutics
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Solid Tumor, Advanced Solid Tumor
Phase 1
Interventional 238 participants sought
University of Arkansas Medical School — Little Rock, Arkansas (4.1 mi)
· Sponsor: NiKang Therapeutics, Inc.
Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB)
Heavy Menstrual Bleeding
N/A
Interventional 7 participants sought
Applied Research Center of Arkansas — Little Rock, Arkansas (4.1 mi)
· Sponsor: Rejoni Inc.
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Major Depressive Disorder
Phase 3
Interventional 200 participants sought
Neurocrine Clinical Site — Little Rock, Arkansas (4.1 mi)
· Sponsor: Neurocrine Biosciences
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Preferred Research Partners /ID# 270389 — Little Rock, Arkansas (4.1 mi)
· Sponsor: AbbVie
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
University of Arkansas — Little Rock, Arkansas (4.1 mi)
· Sponsor: Lyell Immunopharma, Inc.
Using Virtual Reality Technology to Improve Patient Experience and Quality of Care During Brachytherapy
Endocervical Cancer
N/A
Interventional 20 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: University of Arkansas
Encore PFO Closure Device - The PerFOrm Trial
Patent Foramen Ovale, Cryptogenic Stroke
N/A
Interventional 500 participants sought
Arkansas Cardiology — Little Rock, Arkansas (4.1 mi)
· Sponsor: Encore Medical Inc.
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8
Phase 3
Interventional 3,680 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Platinum-resistant Ovarian Cancer, Testicular Cancer
Phase 1
Interventional 156 participants sought
University of Arkansas Winthrop P. Rockefeller Cancer Institute — Little Rock, Arkansas (4.1 mi)
· Sponsor: Context Therapeutics Inc.
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
University of Arkansas for Medical Sciences — Little Rock, Arkansas (4.1 mi)
· Sponsor: NRG Oncology
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Arkansas Cardiology — Little Rock, Arkansas (4.1 mi)
· Sponsor: Duke University
Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC
Neurogenic Detrusor Overactivity
Phase 2, Phase 3
Interventional 71 participants sought
Arkansas Childrens Hospital — Little Rock, Arkansas (4.1 mi)
· Sponsor: Urovant Sciences GmbH